(PRWEB) July 23, 2012
The global ophthalmology market witnessed a dip in 2008 and 2009 due to the economic downturn; however, it is poised to grow at a stable rate, owing to rising incidences of ophthalmic disorders such as glaucoma and cataract. Blindness is one of the major consequences of cataract; about 48% of the cataract population is completely blind. On the other hand, about 60 million people suffer from glaucoma. This number is expected to reach 80 million by 2020.
Age is the dominant factor for ophthalmic disorders. The global population that is aging rapidly also suffers from refractive errors. Refractive errors affect more than 30% of the population aged 40 years and/or above in the U.S. and Europe. Apart from this, increasing LASIK procedures will propel the market growth.
The report studies the ophthalmology drugs market and ophthalmology devices market. The ophthalmology devices market is segmented by diagnostic and surgical devices. The drugs market will be analyzed on the basis of current and pipeline drugs, with a market forecast until 2020. This market will also be studied by formulation types like capsules, gels, eye drops, ointment, and eye solutions.
The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (ROW). APAC is an unsaturated market, especially China and India, and these regions are expected to drive the growth of the overall ophthalmology market.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Email: sales (at) marketsandmarkets (dot) com